FATE Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Fate Therapeutics Inc (FATE) is not a strong buy for a beginner, long-term investor at this time. While the technical indicators show some short-term bullish momentum, the company's financial performance is weak, with significant revenue and net income declines. Additionally, there are no recent positive news catalysts, analyst upgrades, or influential trading activity to support a strong buy decision. The options data also indicates minimal bullish sentiment, and the stock's future growth prospects appear uncertain.
The MACD is positive and expanding, indicating short-term bullish momentum. RSI is neutral at 69.256, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). The stock is trading above key support levels, with resistance at 1.401 and 1.476. However, the overall technical setup does not strongly suggest a long-term buying opportunity.
Bullish moving averages and positive MACD expansion. Gross margin remains at 100%.
Significant YoY declines in revenue (-26.40%), net income (-37.92%), and EPS (-38.64%). No recent news, analyst upgrades, or influential trading activity. Hedge funds and insiders are neutral, with no significant trading trends.
In 2025/Q4, revenue dropped to $1.369M (-26.40% YoY), net income dropped to -$32.374M (-37.92% YoY), and EPS dropped to -0.27 (-38.64% YoY). Gross margin remained at 100%.
No recent analyst ratings or price target changes available.
